Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 07-Aug-24 4:05 PM View:  | Sage Therapeutics, Inc. (SAGE) | 05-Aug-24 | Grant | 50,400 | -- | -- | 107% 46.94K to 97.34K | |
| 07-Aug-24 4:05 PM View: | Sage Therapeutics, Inc. (SAGE) | 05-Aug-24 | Payment of Exercise | 12,273 | $8.96 | $109,966.00 | (13%) 97.34K to 85.07K | |
| 15-Nov-22 4:04 PM View: | Sage Therapeutics, Inc. (SAGE) | 10-Nov-22 | Private Purchase | 14,500 | $34.48 | $500,022.00 | 45% 32.44K to 46.94K | |
| 15-Aug-22 8:05 AM View: | Karyopharm Therapeutics, Inc. (KPTI) | 11-Aug-22 | Option Exercise | 7,576 | $1.49 | $11,250.40 | 126% 6.03K to 13.61K | |
| 09-Aug-21 9:07 AM View: | Sage Therapeutics, Inc. (SAGE) | 05-Aug-21 | Market Purchase | 23,640 | $43.15 | $1,020,050.00 | 269% 8.8K to 32.44K | (5%) |
| 17-Jun-21 9:14 AM View: | Sage Therapeutics, Inc. (SAGE) | 16-Jun-21 | Market Purchase | 8,800 | $56.32 | $495,627.00 | 100% 0 to 8.8K | (3%) |
| 11-Sep-20 5:11 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Sep-20 | Option Exercise | 44,530 | $9.14 | $407,004.00 | 61% 73.5K to 118.03K | |
| 11-Sep-20 5:11 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Sep-20 | Market Option Sale (Planned) | 44,530 | $123.23 | $5,487,590.00 | (38%) 118.03K to 73.5K | |
| 11-Aug-20 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Aug-20 | Option Exercise | 4,931 | $70.95 | $349,871.00 | 7% 68.72K to 73.66K | < 1% |
| 11-Sep-20 5:11 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Jul-20 | Gift | 3,176 | -- | -- | 5% 68.72K to 71.9K | |
| 11-Sep-20 5:11 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Jul-20 | Gift | 155 | -- | -- | < 1% 71.9K to 72.06K | |
| 11-Sep-20 5:11 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Jul-20 | Gift | 3,486 | -- | -- | (5%) 72.06K to 68.57K | |
| 09-Jul-20 4:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Jul-20 | Option Exercise | 22,265 | $9.14 | $203,502.00 | 32% 68.72K to 90.99K | |
| 09-Jul-20 4:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Jul-20 | Market Option Sale (Planned) | 22,265 | $159.99 | $3,562,180.00 | (24%) 90.99K to 68.72K | |
| 07-May-20 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 06-May-20 | Option Exercise | 22,265 | $9.14 | $203,502.00 | 32% 68.72K to 90.99K | |
| 07-May-20 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 06-May-20 | Market Option Sale (Planned) | 22,265 | $149.99 | $3,339,530.00 | (24%) 90.99K to 68.72K | |
| 09-Apr-20 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Apr-20 | Grant | 5,417 | -- | -- | 8% 64.97K to 70.39K | |
| 09-Apr-20 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Apr-20 | Payment of Exercise | 1,663 | $104.82 | $174,321.00 | (2%) 70.39K to 68.72K | |
| 17-Mar-20 5:35 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 13-Mar-20 | Option Exercise | 3,030 | $0.03 | $99.99 | 101% 3.0K to 6.03K | |
| 24-Oct-19 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 23-Oct-19 | Acquisition (other) | 5,544 | -- | -- | 9% 64.97K to 70.52K | |
| 24-Oct-19 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 23-Oct-19 | Disposition (other) | 5,544 | -- | -- | (8%) 70.52K to 64.97K | |
| 24-Oct-19 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Oct-19 | Option Exercise | 58,913 | $16.43 | $967,941.00 | 91% 64.97K to 123.88K | |
| 24-Oct-19 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Oct-19 | Market Option Sale (Planned) | 58,913 | $89.99 | $5,301,580.00 | (48%) 123.88K to 64.97K | |
| 07-Aug-19 4:16 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 11-Jul-19 | Acquisition (other) | 46 | -- | -- | < 1% 64.92K to 64.97K | |
| 07-Jun-19 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Apr-19 | Acquisition (other) | 52 | -- | -- | < 1% 64.87K to 64.92K | |
| 07-Jun-19 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Oct-18 | Acquisition (other) Duplicate | 21 | -- | -- | < 1% 64.85K to 64.87K | |
| 14-Aug-18 7:14 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 31-Jul-18 | Gift | 9,030 | -- | -- | 14% 64.85K to 73.88K | |
| 14-Aug-18 7:14 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 31-Jul-18 | Gift | 9,030 | -- | -- | (12%) 73.88K to 64.85K | |
| 14-Aug-18 7:14 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Jul-18 | Acquisition (other) Duplicate | 29 | -- | -- | < 1% 64.82K to 64.85K | |
| 23-May-18 7:35 AM View: | Acorda Therapeutics, Inc. (ACOR) | 21-May-18 | Payment of Exercise | 8,727 | $23.10 | $201,594.00 | (87%) 10.0K to 1.27K | 97% |
| 23-May-18 7:35 AM View: | Acorda Therapeutics, Inc. (ACOR) | 21-May-18 | Option Exercise | 10,000 | $20.16 | $201,600.00 | 100% 0 to 10.0K | |
| 14-Aug-18 7:14 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Apr-18 | Acquisition (other) Duplicate | 28 | -- | -- | < 1% 64.8K to 64.82K | |
| 16-Mar-18 5:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 14-Mar-18 | Market Sale (Planned) | 38,460 | $143.10 | $5,503,740.00 | (37%) 103.24K to 64.78K | 42% |
| 14-Aug-18 7:14 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 17-Jan-18 | Acquisition (other) | 17 | -- | -- | < 1% 64.78K to 64.8K | |
| 04-Oct-17 7:45 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Oct-17 | Option Exercise | 85,316 | $21.35 | $1,821,500.00 | 83% 103.24K to 188.55K | |
| 04-Oct-17 7:45 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Oct-17 | Market Option Sale (Planned) | 85,316 | $125.00 | $10,664,500.00 | (45%) 188.55K to 103.24K | 33% |
| 22-Sep-17 5:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Sep-17 | Option Exercise | 11,844 | $12.33 | $146,042.00 | 13% 91.39K to 103.24K | |
| 22-Sep-17 5:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Sep-17 | Option Exercise | 76,815 | $31.39 | $2,411,220.00 | 84% 91.39K to 168.21K | |
| 22-Sep-17 5:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Sep-17 | Market Option Sale (Planned) | 76,815 | $100.00 | $7,681,500.00 | (46%) 168.21K to 91.39K | 16% |
| 03-Aug-17 4:06 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Aug-17 | Option Exercise | 10,000 | $18.21 | $182,100.00 | 100% 0 to 10.0K | |
| 03-Aug-17 4:06 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Aug-17 | Market Option Sale (Planned) | 10,000 | $21.57 | $215,697.00 | (100%) 10.0K to 0 | 97% |
| 13-Feb-17 4:14 PM View: | Acorda Therapeutics, Inc. (ACOR) | 09-Feb-17 | Option Exercise | 723 | $22.13 | $16,000.00 | 100% 0 to 0.72K | (97%) |
| 13-Feb-17 4:14 PM View: | Acorda Therapeutics, Inc. (ACOR) | 09-Feb-17 | Market Option Sale (Planned) | 723 | $22.65 | $16,376.00 | (100%) 0.72K to 0 | 97% |
| 05-Jan-17 4:12 PM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Jan-17 | Option Exercise | 3,017 | $15.91 | $48,000.50 | 100% 0 to 3.02K | |
| 05-Jan-17 4:12 PM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Jan-17 | Market Option Sale (Planned) | 3,017 | $19.26 | $58,112.90 | (100%) 3.02K to 0 | 96% |
| 05-Dec-16 4:55 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Dec-16 | Option Exercise | 55,605 | $22.75 | $1,265,010.00 | 82% 67.52K to 123.12K | |
| 05-Dec-16 4:55 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Dec-16 | Market Option Sale (Planned) | 31,825 | $42.99 | $1,368,130.00 | (26%) 123.12K to 91.3K | (94%) |
| 28-Mar-16 5:27 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 24-Mar-16 | Option Exercise | 16,540 | $8.20 | $135,672.00 | 33% 50.88K to 67.42K | |
| 22-Dec-15 4:50 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Nov-15 | Gift | 2,100 | -- | -- | (4%) 52.98K to 50.88K | |
| 06-Aug-15 5:32 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Aug-15 | Option Exercise | 26,972 | $18.73 | $505,124.00 | 104% 26.0K to 52.98K |